Press Releases
Mayo Clinic Teams with Glowing Cats Against AIDS, Other...
Mayo Clinic researchers have developed a genome-based immunization strategy to fight feline AIDS and illuminate ways to combat human HIV/AIDS and other diseases. The...
Press Releases
Exelixis Announces Webcasts of Upcoming Investor Conference Presentations Exelixis...
Exelixis, Inc. announced today that Michael Morrissey, PhD, the company’s president and chief executive officer, will present at two upcoming investor conferences. ...
Press Releases
Sucampo and Numab Sign Drug Discovery Collaboration Sucampo Pharmaceuticals...
Sucampo Pharmaceuticals, Inc. an international pharmaceutical company, and Numab AG today announced that Sucampo’s wholly owned subsidiary, Sucampo AG, and Numab AG, have entered...
Press Releases
Over 65% of Physicians Have Used Social Media to...
Physicians are highly engaged with social media for both personal and professional use, according to a 4,033-clinician study authored and conducted by QuantiaMD, the...
Press Releases
Trophos completes patient enrolment in pivotal efficacy study of...
Marseille France, September 8, 2011 - Trophos SA, a clinical stage pharmaceutical company developing innovative therapeutics from discovery to clinical validation for indications with under-served...
Press Releases
BARDA Partners to Develop New Class of Antibiotic U.S....
The federal government today issued a contract for advanced research and development of a dual-purpose broad spectrum antibiotic with potential to treat illnesses caused...
Press Releases
Synta to Present at the Rodman & Renshaw Annual...
Synta Pharmaceuticals Corp. (NASDAQ:SNTA) today announced that the Company will be presenting at the Rodman & Renshaw Annual Global Investment Conference on Tuesday, September...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.